About BioMrieux
BioMrieux is a Healthcare company founded in 1974. It develops advanced technologies for clinical diagnostics and healthcare applications. It operates on a B2B model. Its focus areas include Biotechnology, Diagnostics and Clinical Technologies.
Company details
BioMrieux develops advanced technologies for clinical diagnostics and healthcare applications through providing healthcare solutions, advancing biotech innovations, offering diagnostic solutions, and clinical technologies. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- SectorsHealthcare
- Website biomerieux-diagnostics.com
Web traffic of BioMrieux
Websites that share an audience with BioMrieux (biomerieux-diagnostics.com).
Websites whose visitors overlap most with BioMrieux. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| biomerieux.com | 99% | 253K | #155,524 | View details | |
| chembio.com | 89% | 4K | – | View details | |
| oriondiagnostica.com | 84% | – | – | View details |
Top companies in Diagnostics & Lab Tech
10 companies that operate in the same segment as BioMrieux (Diagnostics & Lab Tech), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceuticals and diagnostics kits are developed for various diseases. | 1896 | Basel, Basel-stadt, Switzerland | – | USD 77.61 B | 103,250 | |
Point-of-care and laboratory blood analyzers are developed by EKF. | 1990 | Penarth, Wales, United Kingdom | USD 178.63 K | USD 69.43 M | 303 | |
Blood testing services are offered using finger-prick microsamples. | 2017 | Austin, Texas, United States | USD 37.7 M | – | – | |
Manufactures clinical diagnostic test kits | 1971 | Irvine, California, United States | – | USD 4.45 M | 54 | |
Biomarker-based diagnostic solutions for cancer and cardiovascular diseases are developed. | 2002 | Hennigsdorf, Brandenburg, Germany | USD 36.14 M | – | – | |
Diagnostic instrumentation and assays | 1987 | Puteaux, Hauts-de-seine, France | – | – | – | |
Manufacturer of Laboratory equipment | 1955 | Norwood, Massachusetts, United States | – | – | – | |
Cloud based diagnostics platform for point of care diagnosing | 2014 | Waltham, Massachusetts, United States | USD 703.91 M | USD 115.02 K | 9 | |
Diagnostics technology for infectious diseases and health monitoring is provided. | 2012 | Hong Kong, China | USD 34 M | – | – | |
Global leader for In Vitro Diagnostic | 1959 | Barcelona, Catalonia, Spain | – | USD 61.01 M | 346 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about BioMrieux
BioMrieux was founded in 1974.
BioMrieux develops advanced technologies for clinical diagnostics and healthcare applications through providing healthcare solutions, advancing biotech innovations, offering diagnostic solutions, and clinical technologies. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.